Exor N.V. Amends Stellantis 13D Filing, Updates Ownership Info

TL;DR

**Exor N.V. just updated its Stellantis ownership, signaling a change in their stake.**

AI Summary

Exor N.V., a major shareholder in Stellantis N.V., filed an Amendment No. 5 to its Schedule 13D on January 17, 2024. This filing updates information regarding Exor's beneficial ownership of Stellantis's common shares, par value €0.01 per share. While the filing itself doesn't detail specific transactions, it indicates a change in previously disclosed information, which is important for investors to track the holdings of significant insiders like Exor, as their actions can influence stock perception and future strategic decisions.

Why It Matters

This filing matters because Exor N.V. is a significant shareholder in Stellantis, and any changes in their reported ownership or intentions can signal future strategic moves or confidence in the company, potentially impacting stock price.

Risk Assessment

Risk Level: low — This filing is an amendment to a standard disclosure and does not inherently indicate a high-risk event, but rather an update to ownership information.

Analyst Insight

Investors should review the full filing to understand the specific changes in Exor N.V.'s ownership stake or intentions, as this could provide insight into the long-term strategic direction of Stellantis N.V. and potential future share movements.

Key Players & Entities

• Stellantis N.V. (company) — the subject company whose shares are being reported
• Exor N.V. (company) — the reporting person, a major shareholder of Stellantis N.V.
• Scott Miller (person) — contact person for Sullivan & Cromwell LLP, authorized to receive notices
• Sullivan & Cromwell LLP (company) — legal counsel for the reporting person
• €0.01 (dollar_amount) — par value per common share of Stellantis N.V.

FAQ

Filing Documents

• d688194dsc13da.htm (SC 13D/A) — 65KB
• 0001193125-24-012202.txt ( ) — 67KB

is hereby amended and partially restated by replacing the first paragraph with the following

Item 2 is hereby amended and partially restated by replacing the first paragraph with the following: (a)-(c) This Schedule 13D is filed by Exor N.V. (Exor or the Reporting Person), a Dutch public limited liability company ( naamloze vennootschap ) and successor to Exor S.p.A. by virtue of a cross-border merger of Exor S.p.A. with and into Exor. Exor is an investment company, which focuses its business on long-term investments in global companies in diversified sectors, mainly in Europe and the United States. The address of Exors principal business and principal office is Gustav Mahlerplein 25, 1082 MS Amsterdam, the Netherlands. The name, business address, present principal occupation or employment (and the name, principal business and address of any corporation or other organization in which such employment is conducted) and citizenship of each executive officer and director of Exor, each person controlling Exor and each executive officer and director of any corporation or other person in control of Exor are set forth in Schedule A attached hereto. ITEM5. Interest in Securities of the Issuer.

is hereby amended and partially restated by replacing paragraphs (a) through (c) with the following

Item 5 is hereby amended and partially restated by replacing paragraphs (a) through (c) with the following: (a) Rows (11) and (13) of the cover page to this Amendment No. 5 are incorporated by reference herein. (b) Rows (7) through (10) of the cover page to this Amendment No. 5 are hereby incorporated by reference herein. Furthermore, the following persons listed in Item 2(a)(c) above beneficially own common shares of the Issuer: Mr. John Elkann owns 1,047,609 common shares of record; Mr. Niccolò Camerana owns 5,499 common shares of record; and Mr. Alessandro Nasi owns 3,750 common shares of record. The persons listed in Schedule A hereto and named in Item 5 above have the sole voting power and sole dispositive power in respect of the entire number of shares indicated in this Item 5, above. There are no other persons known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities. (c) Neither the Reporting Person nor any persons listed in Schedule A have effected any transactions with respect to common shares of the Issuer during the past 60 days. (d) There are no changes to the information set out in paragraph (d) of Item 5 of the Original 13D, as amended, and such information is incorporated by reference herein. (e) There are no changes to the information set out in paragraph (e) of Item 5 of the Original 13D, as amended, and such information is incorporated by reference herein. 3 SIGNATURE After reasonable inquiry and to the best of the undersigneds knowledge and belief, the undersigned hereby certifies that the information set forth in this statement is true, complete and correct. Date: January 22, 2024 Exor N.V. By: /s/ Guido de Boer Name: Guido de Boer Title: Authorized Signatory 4 SCHEDULE A Schedule A is hereby amended by deleting the previous response in its entirety and replacing it with the following: Exor N.V. (Exor) Set forth bel

View Full Filing

View this SC 13D/A filing on SEC EDGAR